News

Jungbunzlauer Introduces Innovative Gummy Mineral Solutions

Jungbunzlauer Introduces Innovative Gummy Mineral Solutions

Jungbunzlauer Unveils Exciting Developments at IFT FIRST 2025

In an impressive display of innovation, Jungbunzlauer, a global frontrunner in sustainable, high-quality ingredients derived from natural sources, is preparing to showcase its latest cutting-edge solutions in gummy supplements at the upcoming IFT FIRST 2025 event. Among the highlights will be their optimized organic minerals, specially crafted to meet the increasing consumer demand for enjoyable and effective alternatives to traditional supplements.

Rapid Growth in the Gummy Supplement Sector

The gummy supplement market is on a remarkable trajectory, with projections indicating that it could double in size by 2030, reaching a staggering $52.2 billion. Interestingly, nearly two-thirds of U.S. adults now show a preference for gummies over pills. This trend reflects a significant shift in consumer behavior, and Jungbunzlauer's offerings are tailored to cater to these evolving preferences.

Innovative Formulation Solutions

To further support this growing demand, Jungbunzlauer is excited to introduce a variety of innovative formulation solutions based upon a strong foundation of organic mineral salts. Their portfolio includes well-established ingredients like zinc and calcium citrates. The latest addition, a finely developed magnesium citrate granulation, promises to deliver a smoother texture, better taste, and enhanced bioavailability in gummy formulations. The company's research and development efforts demonstrate that the right combination of fine granulation and carefully tuned processing can optimize sensory experiences and nutrient delivery in both pectin and gelatin-based products.

Commitment to Quality and Performance

Markus Gerhart, Senior Director of the Mineral and Solutions portfolio at Jungbunzlauer, emphasized their commitment to quality and innovation, stating, "These solutions epitomize our commitment as a company that values quality, innovation, and trust. It is crucial that our gummies not only taste excellent but also perform effectively. Our solutions enable brands to provide a top-notch consumer experience without compromise."

Key Advantages of Jungbunzlauer's Range

Jungbunzlauer’s innovations boast several key features and advantages:

  • High bioavailability: Organic citrate salts are efficiently absorbed by the body.
  • Improved sensory experience: Micronized forms offer a smoother texture and reduced sandiness.
  • High dosage potential: Suitable for nutritional and health claims.
  • Neutral taste and odor: Maintains quality even at high fortification levels.
  • Excellent dispersibility: Ensures uniform distribution and a smooth texture.
  • Good processability: Compatible with both pectin and gelatin formulations.

Reliable and Sustainable Ingredient Solutions

Produced with the same expertise and reliability for which Jungbunzlauer is well-known, these organic minerals serve as versatile solutions to support high bioavailability and clean-label requirements, all while adhering to sustainable practices. Their portfolio spans acidulants, sweeteners, and texturants, ensuring quality without compromise.

Join Jungbunzlauer at IFT FIRST 2025

Industry professionals attending IFT FIRST 2025 from the 13th to the 16th of July will find Jungbunzlauer at Booth S723, where their technical team will be on hand to explore how these innovative ingredients can help manufacturers adapt to shifting consumer expectations.

About Jungbunzlauer

Jungbunzlauer is recognized as a leading provider of high-quality and sustainable ingredients sourced from nature, catering to a variety of industries including food and beverage, nutrition, and personal care. The company is dedicated to developing naturally superior ingredients that enhance everyday life. With a diverse array of texturants, acidulants, sweeteners, minerals, and customized solutions, Jungbunzlauer is committed to addressing the ever-changing needs of its customers.

Headquartered in Basel, Switzerland, Jungbunzlauer operates state-of-the-art facilities, including extensive fermentation operations in Europe and North America. The company proudly serves over 130 countries worldwide and has grown into a CHF 1.3 billion entity, driven by nearly 1,400 dedicated team members focused on fostering a healthier and more sustainable future. For more information, please visit www.jungbunzlauer.com.

Frequently Asked Questions

What innovations is Jungbunzlauer showcasing?

Jungbunzlauer is showcasing new formulations of organic minerals specifically designed for gummy supplements.

When and where is IFT FIRST 2025 taking place?

IFT FIRST 2025 will take place from July 13 to July 16 at the McCormick Place in Chicago.

What are the key advantages of Jungbunzlauer's gummy solutions?

Key advantages include high bioavailability, improved sensory experience, and excellent processability.

Who is the Senior Director of the Mineral and Solutions portfolio at Jungbunzlauer?

Markus Gerhart is the Senior Director responsible for the Mineral and Solutions portfolio.

How long has Jungbunzlauer been in operation?

Jungbunzlauer has been operational for over 150 years, focusing on sustainable ingredient development.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

DCHFA Appoints Dr. Moreiça Allana-Kim Ortega for Strategic Leadership

Updated Category News Views 325

DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...

Continue Reading
Cboe Hits Milestone of 1,000 ETFs, Showcasing Growth Trend

Updated Category News Views 120

Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...

Continue Reading
Eat Happy Kitchen Expands Reach with Nationwide Kroger Partnership

Updated Category News Views 1256

Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...

Continue Reading
ThreeD Capital Reveals December Net Asset Value of $0.76

Updated Category News Views 183

Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...

Continue Reading
Innovative Wealth Planning Tool by Simon Quick Advisors Unveiled

Updated Category News Views 112

Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...

Continue Reading